Skip to main content
. 2023 Jun 23;30(9):1285–1295. doi: 10.1038/s41417-023-00637-8

Fig. 1. EWS cells release IGF2BP3 loaded into EVs.

Fig. 1

a IGF2BP3 levels in supernatants from EWS cells evaluated by ELISA assay. The bars represent the mean ± SE of two independent biological experiments with at least two replicates/each. b on the left, a schematic of the experimental plan to obtain EVs and EVs-depleted supernatant. The figure was created with BioRender.com; on the right, western blotting showing IGF2BP3 expression in complete supernatant (Pre-EQ S), EVs-depleted supernatant (Post-EQ S) and EVs obtained from A673, TC-71 and EW#5-C cells. Representative western blots of at least two independent experiments are shown. c Western blots depicting the expression of IGF2BP3 and EVs markers (TSG101 and ALIX) are shown. Protein analysis was performed on lysates from IGF2BP3-depleted (#18, #54, #46, #73, sg-IGF2BP3-1, sg-IGF2BP3-2), parental or mock-silenced (shNC and sgNC) cells and related EVs. CALN was used as a control to confirm that EVs were not contaminated with cellular material.